BUCKHEAD CAPITAL MANAGEMENT LLC - GALENA BIOPHARMA INC ownership

Quarter-by-quarter ownership
BUCKHEAD CAPITAL MANAGEMENT LLC ownership history of GALENA BIOPHARMA INC
ValueSharesWeighting
Q3 2016$4,000
-20.0%
10,6400.0%0.00%0.0%
Q2 2016$5,000
-64.3%
10,6400.0%0.00%
-66.7%
Q1 2016$14,000
-12.5%
10,6400.0%0.00%0.0%
Q4 2015$16,000
-5.9%
10,6400.0%0.00%0.0%
Q3 2015$17,000
-5.6%
10,6400.0%0.00%0.0%
Q2 2015$18,000
-18.2%
10,640
-31.5%
0.00%
-25.0%
Q1 2015$22,000
+22.2%
15,530
+33.5%
0.00%
+33.3%
Q4 2014$18,000
-25.0%
11,6300.0%0.00%
-25.0%
Q3 2014$24,00011,6300.00%
Other shareholders
GALENA BIOPHARMA INC shareholders Q3 2023
NameSharesValueWeighting ↓
Hoxton Financial, Inc. 50,000$74,0000.04%
Alyeska Investment Group, L.P. 1,593,277$2,342,0000.02%
DUMONT & BLAKE INVESTMENT ADVISORS LLC 31,000$46,0000.02%
GROUP ONE TRADING, L.P. 1,346,904$1,980,0000.02%
Matisse Capital 17,000$25,0000.01%
COMPTON CAPITAL MANAGEMENT INC /RI 15,000$22,0000.01%
SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) 12,150$18,0000.01%
EQUITEC SPECIALISTS, LLC 19,700$29,0000.01%
LADENBURG THALMANN FINANCIAL SERVICES INC. 153,375$225,0000.00%
OPPENHEIMER & CO INC 94,300$138,0000.00%
View complete list of GALENA BIOPHARMA INC shareholders